1417526-07-8

Basic information

• Product Name: methyl-2-(2-((4-fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetate
• Synonyms: methyl-2-(2-((4-fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetate
• CAS NO: 1417526-07-8
• Molecular Weight: 348.398
• Mol File: 1417526-07-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: methyl-2-(2-((4-fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl-2-(2-((4-fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetate(1417526-07-8)
• EPA Substance Registry System: methyl-2-(2-((4-fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetate(1417526-07-8)

Safety Data

• Hazardous Substances Data: 1417526-07-8(Hazardous Substances Data)

Upstream product

• 451487-18-6 2-[(4-fluorobenzyl)sulfanyl]-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one 
• 88016-31-3 (trifluoromethanesulfonyloxy)acetic acid methyl ester 
• 10472-24-9 methyl 2-oxocyclopentane-1-carboxylate 
• 96-32-2 bromoacetic acid methyl ester 
• 459-46-1 4-Fluorobenzyl bromide 

Downstream Products

• 1417526-10-3 2-(2-(4-fluorobenzylthio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetonitrile 
• 1417526-11-4 (Z)-2-(2-(4-fluorobenzylthio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)-N'-hydroxyacetimidamide 
• 1417526-26-1 2-oxo-2-phenylethyl 2-(2-(4-fluorobenzylthio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetate 
• 1417526-74-9 2-(4-fluorobenzylthio)-1-((5-n-heptyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)methyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417526-81-8 (E)-2-(4-fluorobenzylthio)-1-((5-n-heptyl-4-(n-oct-1-enyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)methyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417531-17-9 2-(4-fluorobenzylthio)-1-((5-phenyl-1H-imidazol-2-yl)methyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417527-01-5 1-((1H-tetrazol-5-yl)methyl)-2-(4-fluorobenzylthio)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 356058-42-9 {2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}acetic acid 
• 1417526-08-9 2-(2-(4-fluorobenzylthio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetamide 

Relevant articles and documents

RADIOLABELED DARAPLADIB AND ANALOGS THEREOF AND THEIR USE AS IMAGING COMPOUNDS

The present inventors have developed new radiolabeled Darapladib and analogs thereof which can be used for the specific detection of vulnerable atherosclerotic plaques by targeting lipoprotein-associated phospholipase A2 (Lp-PLA2) which is a biomarker of

AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE

The present invention relates to the filed of pharmarcutical chemistry, and in particular, to a novel class of azole compounds represented by general formula (I), (II) or (III) amd a preparation method thereof, a pharmarcutical composition with the compounds as active components, and a use of the azole compounds and the pharmarcutical composition in the preparation of a medicament for treatment of diseases associated with Lp-PLA2 enzyme activities, wherein each substituent is as deinfed in the specifictaion.